Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genocea Biosciences Inc (NASDAQ:GNCA)

2.75
Delayed Data
As of Feb 10
 -0.05 / -1.79%
Today’s Change
2.56
Today|||52-Week Range
16.18
-47.82%
Year-to-Date

Today’s Trading

Previous close2.80
Today’s open2.85
Day’s range2.72 - 3.18
Volume187,540
Average volume (3 months)303,451
Market cap$78.7M
Dividend yield--
Data as of 02/10/2016

Growth & Valuation

Earnings growth (last year)+96.99%
Earnings growth (this year)+19.79%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.54

Competitors

 Today’s
change
Today’s
% change
PTIEPain Therapeutics In...+0.04+2.31%
AUPHAurinia Pharmaceutic...+0.02+0.81%
PLXProtalix Biotherapeu...0.000.00%
CFRXContraFect Corp+0.08+2.56%
Data as of 4:02pm ET, 02/10/2016

Financials

Last reporting dateFebruary 11, 2016
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$0.00
Annual profit (last year)-$35.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
William D. Clark
Chief Financial Officer
Jonathan Michael Poole
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers